Avecho Biotechnology Limited
AVEFF
$0.0045
-$0.0129-74.14%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 10.26% | 8.61% | 8.04% | -11.03% | -42.50% |
| Total Depreciation and Amortization | -19.66% | -24.88% | -30.36% | -28.35% | -25.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -89.30% | -79.25% | -73.54% | -44.06% | 128.44% |
| Change in Net Operating Assets | -172.96% | -1,105.28% | -242.03% | -242.03% | -242.03% |
| Cash from Operations | -25.63% | -42.39% | -64.47% | -74.05% | -86.41% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -231.25% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.45% | -3.01% | 2.12% | 6.94% | 11.47% |
| Issuance of Common Stock | -- | -39.13% | 211.01% | 621.17% | 400,080.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 26.66% | -450.09% | -1,100.18% | -- |
| Cash from Financing | -88.12% | -31.52% | 194.96% | 617.21% | 8,855.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -177.46% | -132.06% | 863.65% | 388.07% | 320.20% |